Bob Li, AstraZeneca’s Senior Vice President, Global Head of Medical Affairs, Oncology, on why only 7 percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade.
AstraZeneca’s Bob Li on the MARS mission to eliminate cancer
calendar_today
September 6, 2026
domain
mckinsey-and-company